News report 📈 Stocks 🌍 United States

IBEX Reports Record Q4 Revenue of $164M, Issues Strong Fiscal 2027 Outlook

IBEX delivered record fiscal 2026 results driven by health tech expansion and AI momentum, setting a positive trajectory for 2027 with projected revenue growth of up to 11%.

🕐 1 min read

1 assets impacted (Stocks). Net bias: 1 Bullish, 0 Bearish, 0 Neutral. Strongest signal: IBEX ↑ 9/10 (72% confidence).

📊 Affected Assets (1)

IBEX
Bullish 🤖 72%
📅 Short-term 🌍 US · Explicit

IBEX reported record Q4 revenue and issued a strong fiscal 2027 outlook, driving bullish sentiment.

🎯 Key Takeaways

  • Fourth-quarter revenue rose 12% year-over-year to $164.3 million, with full-year revenue reaching $644.1 million.
  • Health tech vertical emerged as a primary growth driver, with quarterly revenue surging 42% to $29.4 million.
  • Management expects fiscal 2027 revenue to hit $700M-$715M, supported by successful AI-agent deployments.
  • The company maintains a strong balance sheet with $30.9 million in net cash and active share repurchases.

📝 Executive Summary

IBEX Limited posted record fourth-quarter revenue of $164.3 million, marking its sixth consecutive quarter of double-digit growth. The company also provided a robust fiscal 2027 outlook, projecting revenue between $700 million and $715 million as it scales its AI-agent deployments across multiple industry verticals.

❓ FAQ

How is IBEX integrating AI into its business model?

IBEX is deploying AI agents to handle enterprise call volumes alongside human agents, aiming to scale client programs more efficiently rather than replacing human staff.

What is the financial outlook for IBEX in fiscal 2027?

IBEX projects fiscal 2027 revenue of $700 million to $715 million and adjusted EBITDA of $90 million to $94 million.